Feedback / Questions
nemvaleukin alfa (ALKS 4230) - Mural Oncology
https://www.globenewswire.com/news-release/2024/05/14/2881205/0/en/Mural-Oncology-Announces-First-Quarter-2024-Financial-Results-and-Provides-Business-Update.html
May 14, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next